A study on siddha trail drug Muruvili Kudineer(int) in patients having Singimantha kanam

An open Non-Randomized clinical trial to Evaluate the efficacy of Muruvili kudineer in Singimantha Kanam(Bronchitis) Among children between 3 to 13 years. - Mv Kudineer

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013286

Enrollment

Registered

2018-04-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Singimantha kanam(Bronchitis)

Interventions

Intervention1: Muruvili Kudineer: 15 to 30 ml Twice a Day administered orally for 7 Days Control Intervention1: NIl: NIl

Eligibility

Inclusion criteria

Inclusion criteria: Age 3-13years Sex:Both Male and Female children Fever Dynpnea Dry or Productive cough Wheezing Patients who are all willing to give blood samples at subsequent visit are involved in this study

Exclusion criteria

Exclusion criteria: Allergic rhinitis Asthma Refluxoesophagitis Upper respiratory infections/common cold Bronchiolitis

Design outcomes

Primary

Measure	Time frame
Primary outcome is mainly assessed by BS Score reduction in clinical symptoms like fever, cough, sputum, dyspnea, wheezing before and after treatmentTimepoint: 7 days	—

Secondary

Measure	Time frame
Secondary outcome is assessed by comparing the safety parameters before and after treatmentTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr Abisha A

Government Siddha Medical College

cspriya2004@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026